These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 6214877)

  • 41. Development of immunocompetent lymphocytes in vivo from murine umbilical cord blood cells.
    Oikawa A; Ito K; Seguchi H; Okabe M; Migishima F; Eshima K; Azuma S; Song SY; Kaneko T; Shinohara N
    Transplantation; 2007 Jul; 84(1):23-30. PubMed ID: 17627233
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Innate immune surveillance of spontaneous B cell lymphomas by natural killer cells and gammadelta T cells.
    Street SE; Hayakawa Y; Zhan Y; Lew AM; MacGregor D; Jamieson AM; Diefenbach A; Yagita H; Godfrey DI; Smyth MJ
    J Exp Med; 2004 Mar; 199(6):879-84. PubMed ID: 15007091
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunologic effects of interleukin 2 in primary immunodeficiency diseases.
    Flomenberg N; Welte K; Mertelsmann R; Kernan N; Ciobanu N; Venuta S; Feldman S; Kruger G; Kirkpatrick D; Dupont B; O'Reilly R
    J Immunol; 1983 Jun; 130(6):2644-50. PubMed ID: 6222111
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Studies on the mechanism of natural killer (NK) cell-mediated cytotoxicity (CMC). I. Release of cytotoxic factors specific for NK-sensitive target cells (NKCF) during co-culture of NK effector cells with NK target cells.
    Wright SC; Bonavida B
    J Immunol; 1982 Jul; 129(1):433-9. PubMed ID: 7086139
    [No Abstract]   [Full Text] [Related]  

  • 45. Immunology. Stress, NK receptors, and immune surveillance.
    Pardoll DM
    Science; 2001 Oct; 294(5542):534-6. PubMed ID: 11567108
    [No Abstract]   [Full Text] [Related]  

  • 46. Enhancement of T. lymphocyte functions by Fc fragments of immunoglobulin. II. Augmentation of the cell-mediated lympholysis response occurs through an Lyt-1+2- helper T cell.
    Morgan EL; Thoman ML; Weigle WO
    J Immunol; 1981 Dec; 127(6):2526-30. PubMed ID: 6457879
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anti-NK cell treatment induces stable mixed chimerism in MHC-mismatched, T cell-depleted, nonmyeloablative bone marrow transplantation.
    Cho SG; Shuto Y; Soda Y; Nakazaki Y; Izawa K; Uchimaru K; Takahashi S; Tani K; Tojo A; Asano S
    Exp Hematol; 2004 Dec; 32(12):1246-54. PubMed ID: 15588949
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Lymphocytes not bearing the typical T- and B-cell markers: their characteristics and effector functions].
    Petrov RV; Khalatian NA; Man'ko VM; Leskov VP
    Usp Sovrem Biol; 1980; 90(2):193-210. PubMed ID: 6160687
    [No Abstract]   [Full Text] [Related]  

  • 49. GVH-reactive lymphocytes are recruited by sensitized syngeneic initiator T-lymphocytes.
    Cohen IR; Livnat S
    Transplant Proc; 1976 Sep; 8(3):393-7. PubMed ID: 10652
    [No Abstract]   [Full Text] [Related]  

  • 50. Suppression of alloreactivity with gamma delta T-cells: relevance to increased gamma delta T-cells following bone marrow transplantation.
    Nagai M; Azuma E; Qi J; Kumamoto T; Hiratake S; Hirayama M; Umemoto M; Komada Y; Sakurai M
    Biomed Pharmacother; 1998; 52(3):137-42. PubMed ID: 9755807
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of donor bone marrow with OKT3 (PAN-T monoclonal antibody) for prophylaxis of graft-vs.-host disease (GvHD) in histocompatible allogeneic bone marrow transplantation (BMT): a pilot study.
    Filipovich AH; McGlave P; Ramsay NK; Goldstein G; Kersey JH
    J Clin Immunol; 1982 Jul; 2(3 Suppl):154S-157S. PubMed ID: 6752174
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interleukin 2-dependent natural killer (NK) cell lines from patients with primary T cell immunodeficiencies.
    Flomenberg N; Welte K; Mertelsmann R; O'Reilly R; Dupont B
    J Immunol; 1983 Jun; 130(6):2635-43. PubMed ID: 6222110
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Natural killer cells and tumor immunity: 1987.
    Hiserodt JC; Herberman RB
    Year Immunol; 1989; 4():201-7. PubMed ID: 2648702
    [No Abstract]   [Full Text] [Related]  

  • 54. Proliferating helper-cell (PHC) test: a possible addition to the armamentarium for histocompatibility testing.
    Bach ML; Bach FH
    Transplant Proc; 1973 Dec; 5(4):1755-7. PubMed ID: 4272830
    [No Abstract]   [Full Text] [Related]  

  • 55. [NK cells--their role and importance in antitumor resistance].
    Mircheva Zh
    Eksp Med Morfol; 1984; 23(2):99-104. PubMed ID: 6205848
    [No Abstract]   [Full Text] [Related]  

  • 56. Disappearance of the NK effect after explantation of lymphocytes and generation of similar nonspecific cytotoxicity correlated to the level of blastogenesis in activated cultures.
    Masucci MG; Klein E; Argov S
    J Immunol; 1980 May; 124(5):2458-63. PubMed ID: 6444972
    [No Abstract]   [Full Text] [Related]  

  • 57. Histocompatibility and natural cell-mediated cytotoxicity.
    Takasugi M; Koide Y; Takasugi J; Akira D; Opelz G
    Transplant Proc; 1979 Jun; 11(2):1332-3. PubMed ID: 157571
    [No Abstract]   [Full Text] [Related]  

  • 58. [Current concepts of the growth mechanisms of the immune response].
    Voĭtenok NN
    Ter Arkh; 1980; 52(9):132-40. PubMed ID: 6449091
    [No Abstract]   [Full Text] [Related]  

  • 59. Tolerant T cells inhibit natural killer cells function in antigen-presenting cells in an independent fashion.
    Wang X; Yuan J; Hu J; Wu J; Gan C; He W; Luo G
    Transplant Proc; 2009 Jun; 41(5):1844-7. PubMed ID: 19545741
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Induction of graft-versus-leukemia (GVL) activity in murine leukemia models after IL-2 pretreatment of syngeneic and allogeneic bone marrow grafts.
    Zeis M; Uharek L; Glass B; Gaska T; Gassmann W; Mueller-Ruchholtz W
    Bone Marrow Transplant; 1994 Nov; 14(5):711-5. PubMed ID: 7889004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.